deltatrials
Unknown PHASE4 INTERVENTIONAL 1-arm NCT01012830

Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia

Huperzine-A for Cognitive Dysfunction and Functional Status in Schizophrenia

Sponsor: American Legion of Iowa Foundation

Conditions Dementia Schizophrenia
Interventions Huperzine A
Updated 4 times since 2017 Last updated: Nov 12, 2009 Started: Dec 31, 2009 Primary completion: Dec 31, 2010 Completion: Apr 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Dementia and Schizophrenia and is currently ongoing. American Legion of Iowa Foundation leads this study, which shows 4 recorded versions since 2009 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jan 2017 – ~Jan 2021 · 48 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE4

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE4

  4. Jan 2017 — Jan 2021 [monthly]

    Unknown Status PHASE4

    First recorded

Dec 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • American Legion of Iowa Foundation
  • VA Nebraska Western Iowa Health Care System
Data source: VA Nebraska Western Iowa Health Care System

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations